Organ transplant immunosuppressant drugs market to reach $6.85 billion by 2030 at 4.8% cagr, driven by increasing demand for organ transplantation.
Read More
Orencia abatacept drug market to reach $5.28 billion by 2030 at 6.1% cagr, driven by increasing prevalence of autoimmune diseases and rising personalized medicine.
Read More
Orally disintegrating tablet market to reach $24.43 billion by 2030 at 8.5% cagr, driven by increasing incidence of neurological disorders.
Read More
Oral vaccine market to reach $6.29 billion by 2030 at 9.7% cagr, driven by rising prevalence of infectious diseases.
Read More
Oral transmucosal drugs market to reach $63.76 billion by 2030 at 7.8% cagr, driven by rising incidence of parkinson’s disease.
Read More
Oral solid dosage pharmaceutical formulation market to reach $846.38 billion by 2030 at 5.2% cagr, driven by increasing prevalence of chronic diseases.
Read More
Oral rehydration solution market to reach $6.92 billion by 2030 at 9.4% cagr, driven by increasing incidence of diarrheal diseases.
Read More
Oral proteins and peptides market to reach $4.26 billion by 2030 at 22.2% cagr, driven by growing biopharmaceutical industry.
Read More
Oral mucositis treatment market to reach $3.44 billion by 2030 at 9.9% cagr, driven by increasing use of chemotherapy.
Read More
Oral hypoglycemic agents market to reach $75.62 billion by 2030 at 4.9% cagr, driven by rise in type 2 diabetes prevalence.
Read More